Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus, Current Opinion in Rheumatology, vol.32, issue.2, pp.152-158, 2020. ,
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers, Nature Reviews Neurology, vol.10, issue.10, pp.579-596, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02347338
Peptide inhibition of glomerular deposition of an anti-DNA antibody, Proceedings of the National Academy of Sciences, vol.94, issue.5, pp.1955-1960, 1997. ,
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus, Nature Medicine, vol.7, issue.11, pp.1189-1193, 2001. ,
Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor, EBioMedicine, vol.2, issue.7, pp.755-764, 2015. ,
Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives, Lupus, vol.16, issue.5, pp.329-334, 2007. ,
439 Cerebrovascular events in systemic lupus erythematosus: results from an international, inception cohort study, Poster Session, vol.67, pp.1837-1847, 2017. ,
Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjögren's syndrome: An updated meta-analysis, Autoimmunity Reviews, vol.16, issue.2, pp.114-122, 2017. ,
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, The Lancet Neurology, vol.7, issue.12, pp.1091-1098, 2008. ,
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes, Brain, vol.133, issue.6, pp.1655-1667, 2010. ,
Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain, Journal of Neuroscience, vol.32, issue.32, pp.11082-11094, 2012. ,
The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis, Journal of Neurology, vol.26, pp.1-19, 2019. ,
Autoimmune seizures and epilepsy, Journal of Clinical Investigation, vol.129, issue.3, pp.926-940, 2019. ,
N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications, Annals of Neurology, vol.83, issue.3, pp.553-561, 2018. ,
Detection of interferon alpha protein reveals differential levels and cellular sources in disease, Journal of Experimental Medicine, vol.214, issue.5, pp.1547-1555, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02996522
Synapses pruned in lupus, Nature, vol.546, issue.7659, pp.482-483, 2017. ,
Neuromyelitis optica in patients with increased interferon alpha concentrations, The Lancet Neurology, vol.19, issue.1, pp.31-33, 2020. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02430155
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus, Rheumatology, vol.58, issue.5, pp.908-913, 2018. ,
Fulfilling Koch's postulates of autoimmunity: Anti-NR2 antibodies in mice and men, Arthritis & Rheumatism, vol.54, issue.8, pp.2349-2352, 2006. ,
Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach, Immunological Reviews, vol.284, issue.1, pp.120-131, 2018. ,
Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement, Rheumatology, vol.56, issue.1, pp.77-86, 2016. ,